US4603112A
(en)
*
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US5174993A
(en)
*
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
US5338683A
(en)
*
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
US5110587A
(en)
*
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
US5833975A
(en)
*
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
US7045313B1
(en)
*
|
1982-11-30 |
2006-05-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
|
US5866383A
(en)
*
|
1982-11-30 |
1999-02-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
In vitro ligation of foreign DNA into large eukaryotic viruses
|
CA1310924C
(en)
*
|
1986-04-24 |
1992-12-01 |
Francis P. Mccormick |
Infective drug delivery system
|
FR2604183B1
(fr)
*
|
1986-09-23 |
1988-12-30 |
Transgene Sa |
Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
|
CA1341245C
(en)
*
|
1988-01-12 |
2001-06-05 |
F. Hoffmann-La Roche Ag |
Recombinant vaccinia virus mva
|
EP0398986A4
(en)
*
|
1988-01-20 |
1992-04-15 |
The United States Of America Represented By The Secretary The United States Department Of Commerce |
Plaque transfer assay for detecting retrovirus and measuring neutralizing antibodies
|
US6241982B1
(en)
|
1988-03-21 |
2001-06-05 |
Chiron Corporation |
Method for treating brain cancer with a conditionally lethal gene
|
US6569679B1
(en)
|
1988-03-21 |
2003-05-27 |
Chiron Corporation |
Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
|
US5212057A
(en)
*
|
1988-10-26 |
1993-05-18 |
University Of Florida |
Biological system for constructing and testing viral vaccines
|
US5077213A
(en)
*
|
1988-11-10 |
1991-12-31 |
Shanghai Institute Of Biochemistry, Chinese Academy Of Sciences |
Recombinant vaccinia virus
|
DE69032841T2
(de)
*
|
1989-01-23 |
1999-05-12 |
Chiron Corp |
Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung
|
US6248333B1
(en)
|
1990-04-04 |
2001-06-19 |
Health Research Inc. |
Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
|
US5691170A
(en)
*
|
1989-04-18 |
1997-11-25 |
Therion Biologics |
Generation of hybrid genes and proteins by virus-mediated recombination
|
ATE199398T1
(de)
*
|
1989-10-24 |
2001-03-15 |
Chiron Corp |
Sekretion vom mit gamma-interferon signalpeptid gebundenen humänen protein
|
US5674735A
(en)
*
|
1990-07-06 |
1997-10-07 |
University Court Of The University Of Glasgow |
DNA encoding the EHV-4 gH or gC glycoprotein
|
GB9014950D0
(en)
*
|
1990-07-06 |
1990-08-29 |
Univ Glasgow |
Ehv-4 glycoprotein vaccine
|
US5989886A
(en)
*
|
1991-01-02 |
1999-11-23 |
The Johns Hopkins University |
Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme
|
AU1588092A
(en)
|
1991-02-22 |
1992-09-15 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Transmission blocking vaccine against malaria
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
EP0561034B1
(en)
*
|
1991-08-26 |
1999-06-09 |
IMMUNO Aktiengesellschaft |
Direct molecular cloning of a modified chordopox virus genome
|
US5527700A
(en)
*
|
1992-07-10 |
1996-06-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
Target antigens of transmission blocking antibodies for malaria parasites
|
US5633234A
(en)
*
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
WO1994023745A1
(en)
*
|
1993-04-09 |
1994-10-27 |
The University Of Virginia Patents Foundation |
35/31 kda subunit of the entamoeba histolytica adherence lectin
|
US6296852B1
(en)
|
1993-04-14 |
2001-10-02 |
Commonwealth Scientific And Industrial Research Organisation |
Recombinant avian adenovirus vector
|
CA2158936C
(en)
|
1993-11-18 |
2012-02-21 |
Jack R. Barber |
Compositions and methods for utilizing conditionally lethal genes
|
US5888814A
(en)
*
|
1994-06-06 |
1999-03-30 |
Chiron Corporation |
Recombinant host cells encoding TNF proteins
|
EP0775746B1
(en)
|
1995-07-03 |
2005-11-23 |
Akzo Nobel N.V. |
Coccidiosis poultry vaccine
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US5858373A
(en)
*
|
1995-12-01 |
1999-01-12 |
Virogenetics Corporation |
Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
|
EP1997900A3
(en)
|
1996-04-05 |
2010-10-06 |
Novartis Vaccines and Diagnostics, Inc. |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
WO1998012332A1
(en)
|
1996-09-17 |
1998-03-26 |
Chiron Corporation |
Compositions and methods for treating intracellular diseases
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US5990091A
(en)
|
1997-03-12 |
1999-11-23 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
ATE376062T1
(de)
|
1997-08-04 |
2007-11-15 |
Cell Genesys Inc |
Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
ATE374247T1
(de)
|
1997-10-14 |
2007-10-15 |
Darwin Molecular Corp |
Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
|
AU9363798A
(en)
|
1997-11-06 |
1999-05-31 |
Chiron S.P.A. |
Neisserial antigens
|
EP1042360A2
(en)
|
1997-12-24 |
2000-10-11 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
SG152917A1
(en)
|
1998-01-14 |
2009-06-29 |
Chiron Srl |
Neisseria meningitidis antigens
|
AR020318A1
(es)
|
1998-03-18 |
2002-05-08 |
Corixa Corp |
Una molecula polinucleotidica aislada, un polipeptido aislado codificado por dicha molecula, un vector de expresion, una celula huesped transformada, unaproteina de fusion, una composicion farmaceutica y una vacuna que comprenden dicho polipeptido o proteina; metodos para el tratamiento, deteccion,
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
EP2261347A3
(en)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
KR20060080249A
(ko)
|
1998-06-12 |
2006-07-07 |
마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 |
변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스
|
EP1102790B1
(en)
|
1998-08-07 |
2014-05-07 |
University of Washington |
Immunological Herpes Simplex Virus antigens and methods for use thereof
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US6710172B1
(en)
*
|
1998-10-02 |
2004-03-23 |
Ludwig Institute For Cancer Research |
Tumor antigens and CTL clones isolated by a novel procedure
|
US6407063B1
(en)
|
1998-10-02 |
2002-06-18 |
Ludwig Institute For Cancer Research |
Tumor antigens and CTL clones isolated by a novel procedure
|
EP1953229A3
(en)
|
1998-10-15 |
2008-12-24 |
Novartis Vaccines and Diagnostics, Inc. |
Metastatic breast and colon cancer regulated genes
|
AU769293B2
(en)
|
1998-12-08 |
2004-01-22 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
EP1961813B1
(en)
|
1998-12-16 |
2011-08-10 |
Novartis Vaccines and Diagnostics, Inc. |
Human cyclin-dependent kinase (hPNQALRE)
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
ATE399793T1
(de)
|
1999-04-02 |
2008-07-15 |
Corixa Corp |
Verbindungen und verfahren für therapie und diagnose von lungenkrebs
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
NZ581940A
(en)
|
1999-04-30 |
2011-07-29 |
Novartis Vaccines & Diagnostic |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
AU779978B2
(en)
*
|
1999-10-07 |
2005-02-24 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
DE60038971D1
(de)
|
1999-10-22 |
2008-07-03 |
Aventis Pasteur |
Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene
|
CN1433470A
(zh)
|
1999-10-29 |
2003-07-30 |
启龙股份公司 |
奈瑟球菌的抗原性肽
|
WO2001039722A2
(en)
|
1999-11-30 |
2001-06-07 |
Mayo Foundation For Medical Education And Research |
B7-h1, a novel immunoregulatory molecule
|
JP2003518073A
(ja)
*
|
1999-12-21 |
2003-06-03 |
メリアル |
クリプトスポリジウムパルヴァムと他の腸内病原体の抗原を含む組成物およびワクチン
|
DK1248647T3
(da)
|
2000-01-17 |
2010-09-27 |
Novartis Vaccines & Diagnostic |
Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner
|
DK1265915T3
(da)
|
2000-02-23 |
2011-02-14 |
Glaxosmithkline Biolog Sa |
Nye forbindelser
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
DE60133190T2
(de)
|
2000-04-21 |
2009-04-02 |
CORIXA CORP., Wilmington |
Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
|
US7030219B2
(en)
*
|
2000-04-28 |
2006-04-18 |
Johns Hopkins University |
B7-DC, Dendritic cell co-stimulatory molecules
|
AU2001259291B2
(en)
*
|
2000-04-28 |
2006-11-23 |
Aventis Pasteur Limited |
Improved immunogenicity using a combination of DNA and vaccinia virus vector vaccines
|
EP1282702B1
(en)
*
|
2000-05-10 |
2006-11-29 |
Sanofi Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
CN1606446A
(zh)
|
2000-05-19 |
2005-04-13 |
科里克萨有限公司 |
用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
PT1542732E
(pt)
|
2000-06-20 |
2009-11-06 |
Corixa Corp |
Proteínas de fusão de mycobacterium tuberculosis
|
WO2002000174A2
(en)
|
2000-06-28 |
2002-01-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
CA2414621A1
(en)
*
|
2000-06-30 |
2002-01-10 |
Aros Applied Biotechnology Aps |
Gene expression in biological conditions
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
US7691821B2
(en)
|
2001-09-19 |
2010-04-06 |
University Of South Florida |
Inhibition of SHIP to enhance stem cell harvest and transplantation
|
WO2002032941A2
(en)
|
2000-10-16 |
2002-04-25 |
Proteopharma Aps |
The function of a haptoglobin-haemoglobin receptor and the uses thereof
|
CA2881568C
(en)
|
2000-10-27 |
2019-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from streptococcus groups a & b
|
EP1340088B1
(en)
*
|
2000-11-17 |
2007-01-17 |
University Of Rochester |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
US20050196755A1
(en)
*
|
2000-11-17 |
2005-09-08 |
Maurice Zauderer |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
CN101684158A
(zh)
|
2001-01-17 |
2010-03-31 |
特鲁比昂药品公司 |
结合域-免疫球蛋白融合蛋白
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
US20020108132A1
(en)
*
|
2001-02-02 |
2002-08-08 |
Avigenics Inc. |
Production of a monoclonal antibody by a transgenic chicken
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
US7541512B2
(en)
*
|
2001-03-30 |
2009-06-02 |
Synageva Biopharma Corp. |
Avians containing a lysozyme promoter transgene
|
WO2002079447A2
(en)
|
2001-03-30 |
2002-10-10 |
Avigenics, Inc. |
Avian lysozyme promoter
|
US7176300B2
(en)
*
|
2001-03-30 |
2007-02-13 |
Avigenics, Inc. |
Avian lysozyme promoter
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
GB0109515D0
(en)
*
|
2001-04-17 |
2001-06-06 |
Neg Micon As |
A method for transporting a set of large longitudinal items, a package system to be used by the method and use of such a package system
|
WO2002089747A2
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
EP1281767A3
(en)
|
2001-07-31 |
2003-05-28 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of tumors
|
US7550650B2
(en)
*
|
2001-09-18 |
2009-06-23 |
Synageva Biopharma Corp. |
Production of a transgenic avian by cytoplasmic injection
|
EP2172552A3
(en)
|
2001-10-11 |
2010-07-21 |
Merck Sharp & Dohme Corp. |
Recombinant nucleic acids comprising regions of AD6
|
US7335761B2
(en)
*
|
2001-11-30 |
2008-02-26 |
Avigenics, Inc. |
Avian gene expression controlling regions
|
US6875588B2
(en)
|
2001-11-30 |
2005-04-05 |
Avigenics, Inc. |
Ovomucoid promoter and methods of use
|
US20100333219A1
(en)
*
|
2001-11-30 |
2010-12-30 |
Synageva Biopharma Corp. |
Methods of protein production using ovomucoid regulatory regions
|
US7294507B2
(en)
*
|
2001-11-30 |
2007-11-13 |
Avigenics, Inc. |
Ovomucoid promoters and methods of use
|
NZ533428A
(en)
|
2001-12-12 |
2008-03-28 |
Chiron Srl |
Immunisation against chlamydia trachomatis
|
AU2002365279B2
(en)
|
2001-12-17 |
2009-08-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
US7026465B2
(en)
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
US7135562B2
(en)
*
|
2002-03-14 |
2006-11-14 |
University Of Cincinnati |
Avian iFABP gene expression controlling region
|
US20040241723A1
(en)
*
|
2002-03-18 |
2004-12-02 |
Marquess Foley Leigh Shaw |
Systems and methods for improving protein and milk production of dairy herds
|
EP1864691B1
(en)
|
2002-04-09 |
2011-07-20 |
Sanofi Pasteur Limited |
Modified CEA nucleic acid and expression vectors
|
CA2425021A1
(en)
*
|
2002-04-12 |
2003-10-12 |
Sumitomo Electric Industries, Ltd. |
Control of the ratio of lap to lip
|
US20060094006A1
(en)
*
|
2002-05-01 |
2006-05-04 |
Genoveffa Franchini |
Immunotherapy regimens in hiv-infected patients
|
US20030206916A1
(en)
*
|
2002-05-03 |
2003-11-06 |
Rush-Presbyterian-St. Luke's Medical Center |
Immunogenic peptides
|
ATE494907T1
(de)
|
2002-07-18 |
2011-01-15 |
Univ Washington |
Pharmazeutische zusammensetzungen, die immunologisch aktive herpes simplex virus proteinfragmente enthalten
|
US20070224124A1
(en)
*
|
2002-09-30 |
2007-09-27 |
University Of South Florida |
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
|
US7432351B1
(en)
|
2002-10-04 |
2008-10-07 |
Mayo Foundation For Medical Education And Research |
B7-H1 variants
|
CA2501945A1
(en)
*
|
2002-10-09 |
2004-04-22 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
US20070059329A1
(en)
|
2002-11-15 |
2007-03-15 |
Nathalie Norais |
Unexpected surface proteins in meningococcus
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
ZA200505302B
(en)
|
2003-01-06 |
2007-03-28 |
Corixa Corp |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
CN1980571A
(zh)
*
|
2003-01-24 |
2007-06-13 |
阿维季尼克斯股份有限公司 |
禽类及禽蛋中表达的外源蛋白质
|
EP1606419A1
(en)
|
2003-03-18 |
2005-12-21 |
Quantum Genetics Ireland Limited |
Systems and methods for improving protein and milk production of dairy herds
|
MXPA05010260A
(es)
|
2003-03-27 |
2006-03-17 |
Ottawa Health Research Inst |
Virus de estomatitis vesicular mutantes y usos de los mismos.
|
US7731974B2
(en)
*
|
2003-03-27 |
2010-06-08 |
Ottawa Hospital Research Institute |
Mutant vesicular stomatitis viruses and uses thereof
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
WO2004098634A2
(en)
*
|
2003-04-30 |
2004-11-18 |
Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health |
Protein arginine n-methyltransferase 2 (prmt-2)
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
CN100562570C
(zh)
|
2003-06-18 |
2009-11-25 |
吉恩勒克斯公司 |
修饰的重组痘苗病毒及其它微生物,及其应用
|
US7812116B2
(en)
*
|
2003-07-03 |
2010-10-12 |
Rush University Medical Center |
Immunogenic peptides
|
CA2550583C
(en)
*
|
2003-10-08 |
2013-01-15 |
Sanofi Pasteur, Inc. |
Modified cea /b7 vector
|
MXPA06005424A
(es)
|
2003-11-13 |
2007-01-25 |
Univ Georgia Res Found |
Metodos para caracterizar virus de enfermedad bursal infecciosa.
|
US7763592B1
(en)
|
2003-11-20 |
2010-07-27 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US7807646B1
(en)
*
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US20050202484A1
(en)
|
2004-02-19 |
2005-09-15 |
The Governors Of The University Of Alberta |
Leptin promoter polymorphisms and uses thereof
|
EP1736541B1
(en)
|
2004-03-29 |
2013-01-23 |
Galpharma Co., Ltd. |
Novel modified galectin 9 protein and use thereof
|
EP2199801B1
(en)
|
2004-07-14 |
2013-05-29 |
The Regents of The University of California |
Biomarkers for early detection of ovarian cancer
|
KR20070040824A
(ko)
|
2004-07-30 |
2007-04-17 |
리나트 뉴로사이언스 코퍼레이션 |
아밀로이드-베타 펩티드에 대해 지시된 항체 및 이의 사용방법
|
CA2579764A1
(en)
|
2004-08-10 |
2006-02-23 |
Institute For Multiple Myeloma And Bone Cancer Research |
Methods of regulating differentiation and treating of multiple myeloma
|
US20080085289A1
(en)
|
2004-09-22 |
2008-04-10 |
Cindy Castado |
Immunogenic Composition
|
US7892540B2
(en)
|
2004-10-06 |
2011-02-22 |
Mayo Foundation For Medical Education And Research |
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
|
EP2808384B1
(en)
|
2004-10-08 |
2017-12-06 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Modulation of replicative fitness by using less frequently used synonymous codons
|
US20060194740A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Ulevitch Richard J |
NOD1 as an anti-tumor agent
|
EP1701165A1
(en)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
|
KR20070121814A
(ko)
|
2005-03-31 |
2007-12-27 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
클라미디아 감염에 대비한 백신
|
WO2006115843A2
(en)
|
2005-04-25 |
2006-11-02 |
Merial Limited |
Nipah virus vaccines
|
UY29504A1
(es)
*
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
EP2457926B1
(en)
|
2005-04-29 |
2014-09-24 |
GlaxoSmithKline Biologicals S.A. |
Novel method for preventing or treating M. tuberculosis infection
|
ES2948791T3
(es)
|
2005-06-17 |
2023-09-19 |
Msd Italia Srl |
Vacuna de ácido nucleico contra el virus de la hepatitis C
|
JP4997239B2
(ja)
*
|
2005-07-22 |
2012-08-08 |
ワイズ・エー・シー株式会社 |
抗cd26抗体およびその使用方法
|
ES2460517T3
(es)
|
2005-07-25 |
2014-05-13 |
Emergent Product Development Seattle, Llc |
Reducción de células b mediante el uso de moléculas de unión específica a cd37 y de unión específica a cd20
|
WO2007016597A2
(en)
*
|
2005-07-29 |
2007-02-08 |
The Regents Of The University Of California |
Targeting tnf-alpha converting enzyme (tace)-dependent growth factor shedding in cancer therapy
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
JP2009511636A
(ja)
|
2005-10-18 |
2009-03-19 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド |
アルファウイルスレプリコン粒子による粘膜免疫および全身免疫
|
EP3536704B1
(en)
|
2005-11-14 |
2021-08-25 |
Boehringer Ingelheim Animal Health USA Inc. |
Gene therapy for renal failure
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
US7745158B2
(en)
*
|
2005-12-14 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Detection of secreted aspartyl proteases from Candida species
|
US20090215084A1
(en)
*
|
2006-01-05 |
2009-08-27 |
Mayo Foundation For Medical Education And Research |
B7-h1 and b7-h4 in cancer
|
US20100015642A1
(en)
*
|
2006-01-05 |
2010-01-21 |
Kwon Eugene D |
B7-h1 and survivin in cancer
|
WO2007120368A2
(en)
|
2006-01-09 |
2007-10-25 |
The Regents Of The University Of California |
Immunostimulatory combinations for vaccine adjuvants
|
EP1981905B1
(en)
|
2006-01-16 |
2016-08-31 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Chlamydia vaccine
|
BRPI0709282B8
(pt)
|
2006-03-29 |
2021-05-25 |
Merial Ltd |
vacina contra estreptococos
|
JP5524610B2
(ja)
|
2006-04-07 |
2014-06-18 |
ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク |
トランスコバラミン受容体ポリペプチド、核酸およびその調節因子、ならびに細胞の増殖の調節ならびにガンおよびコバラミン欠損症の処置に使用する関連方法
|
WO2007124361A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Mayo Foundation For Medical Education And Research |
Soluble b7-h1
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
US20100015168A1
(en)
|
2006-06-09 |
2010-01-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
KR101571027B1
(ko)
|
2006-06-12 |
2015-11-23 |
이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 |
효과기 기능을 갖는 단일쇄 다가 결합 단백질
|
CN102026645B
(zh)
|
2006-09-15 |
2016-01-27 |
渥太华医院研究机构 |
溶瘤弹状病毒
|
US20090181078A1
(en)
*
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
LT2484375T
(lt)
|
2006-09-26 |
2018-07-10 |
Infectious Disease Research Institute |
Vakcinos kompozicija, turinti sintetinio adjuvanto
|
US20090098529A1
(en)
*
|
2006-10-16 |
2009-04-16 |
Nanhai Chen |
Methods for attenuating virus strains for diagnostic and therapeutic uses
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
WO2008083169A2
(en)
*
|
2006-12-26 |
2008-07-10 |
The Johns Hopkins University |
Compositions and methods for the treatment of immunologic disorders
|
US7989173B2
(en)
*
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
AU2007339762B2
(en)
*
|
2006-12-27 |
2011-03-31 |
The Johns Hopkins University |
Compositions and methods for treating inflammation and auto-immune diseases
|
KR101471445B1
(ko)
*
|
2007-01-26 |
2014-12-15 |
시나게바 바이오파르마, 코포레이션 |
조류에서 이식유전자 발현
|
WO2008092854A2
(en)
|
2007-01-30 |
2008-08-07 |
Transgene S.A. |
Papillomavirus e2 polypeptide used for vaccination
|
WO2008116116A2
(en)
*
|
2007-03-20 |
2008-09-25 |
Harold Brem |
Gm-csf cosmeceutical compositions and methods of use thereof
|
US20080234194A1
(en)
*
|
2007-03-20 |
2008-09-25 |
Harold Brem |
Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
US20090117034A1
(en)
*
|
2007-06-15 |
2009-05-07 |
Nanhai Chen |
Microorganisms for imaging and/or treatment of tumors
|
ES2725450T3
(es)
|
2007-07-02 |
2019-09-24 |
Etubics Corp |
Métodos y composiciones para la producción de un vector adenoviral para su uso en vacunaciones múltiples
|
AU2008293885A1
(en)
*
|
2007-07-13 |
2009-03-05 |
The John Hopkins University |
B7-DC variants
|
US20110020325A1
(en)
*
|
2008-02-29 |
2011-01-27 |
Kwon Eugene D |
Methods for reducing granulomatous inflammation
|
US10000568B2
(en)
|
2008-04-10 |
2018-06-19 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR in cancer
|
CN102099377A
(zh)
|
2008-04-11 |
2011-06-15 |
新兴产品开发西雅图有限公司 |
Cd37免疫治疗剂及其与双功能化学治疗剂的联合
|
MX2010012069A
(es)
|
2008-05-08 |
2010-12-14 |
Merial Ltd |
Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena.
|
ES2545609T3
(es)
|
2008-08-25 |
2015-09-14 |
Amplimmune, Inc. |
Composiciones de antagonistas de PD-1 y métodos de uso
|
DK2382474T3
(en)
|
2009-01-20 |
2015-04-07 |
Transgene Sa |
SOLUBLE ICAM-1 as a biomarker FOR PREDICTION OF THERAPEUTIC RESPONSE
|
US20100192236A1
(en)
*
|
2009-01-28 |
2010-07-29 |
University Of South Carolina |
Modulation of Delta Opioid Receptor Expression
|
EP2411815B1
(en)
|
2009-03-24 |
2015-11-11 |
Transgene SA |
Biomarker for monitoring patients
|
WO2010117786A1
(en)
|
2009-03-30 |
2010-10-14 |
Mount Sinai School Of Medicine Of New York University |
Influenza virus vaccines and uses thereof
|
DK2998315T4
(da)
|
2009-04-03 |
2022-02-07 |
Boehringer Ingelheim Animal Health Usa Inc |
Newcastle sygdomsvirus-bårne fuglevacciner
|
BRPI1010512A2
(pt)
|
2009-04-17 |
2016-03-15 |
Transgène S A |
"método ex vivo para avaliar a eficácia de um tratamento envolvendo a administração de uma composição imunogênica a um paciente, e, uso de níveis de linfócitos t ativados (cd3 + cd69+) como um biomarcador"
|
US20100284977A1
(en)
*
|
2009-04-28 |
2010-11-11 |
University Of South Carolina |
Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
|
US20100303795A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Soerensen Karina Dalsgaard |
Marker of prostate cancer
|
BRPI1011072B1
(pt)
|
2009-06-05 |
2021-09-28 |
Infectious Disease Research Institute |
Composto de gla, composições de vacina e farmacêutica compreendendo dito composto, bem como uso dos mesmos para estimular, induzir ou acentuar uma resposta imune em um indivíduo
|
AU2010270313B2
(en)
|
2009-07-10 |
2014-05-22 |
Transgene Sa |
Biomarker for selecting patients and related methods
|
CA2771540C
(en)
|
2009-08-21 |
2019-01-15 |
Merial Limited |
Recombinant avian paramyxovirus vaccine and method for making and using thereof
|
AU2010286361A1
(en)
|
2009-08-31 |
2012-03-15 |
Amplimmune, Inc. |
Methods and compositions for the inhibition of transplant rejection
|
AR078253A1
(es)
|
2009-09-02 |
2011-10-26 |
Boehringer Ingelheim Vetmed |
Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
|
EA201290590A1
(ru)
|
2010-01-27 |
2013-03-29 |
Глаксосмитклайн Байолоджикалс С.А. |
Модифицированные туберкулезные антигены
|
RU2575599C2
(ru)
|
2010-03-12 |
2016-02-20 |
Мериал Лимитед |
Рекомбинантные вакцины против вируса "синего языка", их применение
|
AU2011235220B2
(en)
|
2010-03-30 |
2016-03-10 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
US8986706B2
(en)
|
2010-08-31 |
2015-03-24 |
Merial, Inc. |
Newcastle disease virus vectored herpesvirus vaccines
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
WO2012138789A2
(en)
|
2011-04-04 |
2012-10-11 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment
|
AU2012240240A1
(en)
|
2011-04-04 |
2013-05-09 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
MX350795B
(es)
|
2011-04-08 |
2017-09-19 |
Inmune Design Corp |
Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
|
US11149254B2
(en)
|
2011-04-15 |
2021-10-19 |
Genelux Corporation |
Clonal strains of attenuated vaccinia viruses and methods of use thereof
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
JP6407714B2
(ja)
|
2011-04-25 |
2018-10-17 |
アドヴァンスド バイオサイエンス ラボラトリーズ インコーポレイテッド |
短縮型hivエンベロープタンパク質(env)、前記に関連する方法及び組成物
|
US10221218B2
(en)
|
2011-05-10 |
2019-03-05 |
The Regents Of The University Of California |
Adenovirus isolated from titi monkeys
|
US9267112B2
(en)
|
2011-05-10 |
2016-02-23 |
The Regents Of The University Of California |
Adenovirus isolated from Titi Monkeys
|
ES2674439T3
(es)
|
2011-06-01 |
2018-06-29 |
Merial, Inc. |
Administración sin aguja de vacunas contra el VSRRP
|
MX2013013627A
(es)
|
2011-06-21 |
2014-04-25 |
Oncofactor Corp |
Composiciones y metodos para la terapia y diagnostico de cancer.
|
LT2734230T
(lt)
|
2011-07-20 |
2019-03-25 |
Merial Limited |
Rekombinantinė kačių leikemijos viruso vakcina, turinti optimizuotą kačių leukemijos viruso apvalkalo geną
|
CA2844927C
(en)
|
2011-08-12 |
2017-10-31 |
Merial Limited |
Vacuum-assisted preservation of biological products, in particular of vaccines
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
KR20140063747A
(ko)
|
2011-08-29 |
2014-05-27 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
전염증성 상태를 치료 및 예방하기 위한 hdl-관련 분자의 용도
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
US10131695B2
(en)
|
2011-09-20 |
2018-11-20 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
SI2785373T1
(sl)
|
2011-11-30 |
2020-02-28 |
Boehringer Ingelheim Animal Health USA Inc. |
Rekombinantni vektorji HVT, ki izražajo antigene aviarnih patogenov in uporabe le-teh
|
WO2013083753A2
(en)
|
2011-12-07 |
2013-06-13 |
Institut Pasteur |
Identification of a swine parecho-like virus and applications
|
EP2788021B1
(en)
|
2011-12-09 |
2017-01-18 |
Bavarian Nordic A/S |
Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
ES2729967T3
(es)
|
2012-02-07 |
2019-11-07 |
Infectious Disease Res Inst |
Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
|
WO2013138522A2
(en)
|
2012-03-16 |
2013-09-19 |
Genelux Corporation |
Methods for assessing effectiveness and monitoring oncolytic virus treatment
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
WO2013142371A1
(en)
|
2012-03-20 |
2013-09-26 |
Merial Limited |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
US20130280170A1
(en)
|
2012-04-20 |
2013-10-24 |
Aladar A. Szalay |
Imaging methods for oncolytic virus therapy
|
EP3563865A3
(en)
|
2012-05-04 |
2019-12-04 |
Pfizer Inc |
Prostate-associated antigens and vaccine-based immunotherapy regimens
|
PL2850431T3
(pl)
|
2012-05-16 |
2018-09-28 |
Immune Design Corp. |
Szczepionki przeciwko HSV-2
|
US9605276B2
(en)
|
2012-08-24 |
2017-03-28 |
Etubics Corporation |
Replication defective adenovirus vector in vaccination
|
US20140140959A1
(en)
|
2012-10-05 |
2014-05-22 |
Aladar A. Szalay |
Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
|
JP2016508133A
(ja)
|
2012-12-18 |
2016-03-17 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン及びその使用
|
ES2689878T3
(es)
|
2013-02-21 |
2018-11-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Proteínas H5 del virus de la gripe H5N1 para su uso como un medicamento
|
EP2968514A1
(en)
|
2013-03-12 |
2016-01-20 |
Merial, Inc. |
Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
US9302005B2
(en)
|
2013-03-14 |
2016-04-05 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
US20140296139A1
(en)
|
2013-03-15 |
2014-10-02 |
The Regents Of The University Of California |
Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
|
US9428537B2
(en)
|
2013-03-15 |
2016-08-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
tRNA derived small RNAs (tsRNAs) involved in cell viability
|
BR112015025709A2
(pt)
|
2013-04-18 |
2017-07-18 |
Immune Design Corp |
monoterapia com gla para uso em tratamento de câncer
|
US20160083698A1
(en)
|
2013-04-19 |
2016-03-24 |
The Regents Of The University Of California |
Lone star virus
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
CA2953917C
(en)
|
2013-07-01 |
2021-10-19 |
The Research Foundation For The State University Of New York |
Ship inhibition to combat obesity
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
EP3052131B1
(en)
|
2013-10-01 |
2018-12-05 |
Mayo Foundation for Medical Education and Research |
Methods for treating cancer in patients with elevated levels of bim
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
WO2015095811A2
(en)
|
2013-12-20 |
2015-06-25 |
The Board Institute Inc. |
Combination therapy with neoantigen vaccine
|
WO2015103438A2
(en)
|
2014-01-02 |
2015-07-09 |
Genelux Corporation |
Oncolytic virus adjunct therapy with agents that increase virus infectivity
|
CA2943816A1
(en)
|
2014-04-03 |
2015-10-08 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine epidemic diarrhea virus vaccine
|
US10302653B2
(en)
|
2014-05-22 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Distinguishing antagonistic and agonistic anti B7-H1 antibodies
|
AU2015277194B2
(en)
|
2014-06-17 |
2020-10-22 |
The Research Foundation For The State University Of New York |
Ship inhibition to induce activation of natural killer cells
|
EP3161490B1
(en)
|
2014-06-27 |
2019-10-02 |
Abbott Laboratories |
Compositions and methods for detecting human pegivirus 2 (hpgv-2)
|
US10517875B2
(en)
|
2014-07-23 |
2019-12-31 |
Mayo Foundation for Medical Engineering and Research |
Targeting DNA-PKcs and B7-H1 to treat cancer
|
CA2966191A1
(en)
|
2014-11-03 |
2016-05-12 |
Merial, Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
EP3757211A1
(en)
|
2014-12-19 |
2020-12-30 |
The Broad Institute, Inc. |
Methods for profiling the t-cell-receptor repertoire
|
WO2016100975A1
(en)
|
2014-12-19 |
2016-06-23 |
Massachsetts Institute Ot Technology |
Molecular biomarkers for cancer immunotherapy
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
WO2016154010A1
(en)
|
2015-03-20 |
2016-09-29 |
Makidon Paul |
Immunogenic compositions for use in vaccination against bordetella
|
CA2986235A1
(en)
|
2015-05-20 |
2016-11-24 |
The Broad Institute, Inc. |
Shared neoantigens
|
TW202241500A
(zh)
|
2015-06-09 |
2022-11-01 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
EA201890110A1
(ru)
|
2015-06-23 |
2018-05-31 |
Мериал, Инк. |
Рекомбинантные вирусные векторы, содержащие минорные белки prrsv, и способы их получения и применения
|
DK3344289T3
(da)
|
2015-08-31 |
2020-04-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Pestivirusvacciner mod medfødt tremor
|
MX2018003173A
(es)
|
2015-09-16 |
2018-05-17 |
Boehringer Ingelheim Vetmedica Inc |
Vacunas de salmonella choleraesuis-salmonella typhimurium.
|
CA2999138C
(en)
|
2015-09-21 |
2024-05-21 |
Aptevo Research And Development Llc |
Cd3 binding polypeptides
|
WO2017062246A1
(en)
|
2015-10-05 |
2017-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human rota virus g9p[6] strain and use as a vaccine
|
US10875923B2
(en)
|
2015-10-30 |
2020-12-29 |
Mayo Foundation For Medical Education And Research |
Antibodies to B7-H1
|
US10780158B2
(en)
|
2015-11-16 |
2020-09-22 |
Georgia State University Research Foundation, Inc. |
Tunable vaccine platform against pathogens of the paramyxovirus family
|
PL3402802T3
(pl)
|
2016-01-08 |
2023-06-05 |
Geovax, Inc. |
Kompozycje i sposoby generowania odpowiedzi immunologicznej względem antygenu powiązanego z guzem nowotworowym
|
CA2954892A1
(en)
|
2016-01-19 |
2017-07-19 |
Pfizer Inc. |
Immunogens derived from tumor-associated antigens or nucleic acid molecules encoding the immunogens
|
US20190346442A1
(en)
|
2016-04-18 |
2019-11-14 |
The Broad Institute, Inc. |
Improved hla epitope prediction
|
EP4112638A1
(en)
|
2016-05-16 |
2023-01-04 |
Access to Advanced Health Institute |
Formulation containing tlr agonist and methods of use
|
EP3463300A1
(en)
|
2016-06-01 |
2019-04-10 |
Infectious Disease Research Institute |
Nanoalum particles containing a sizing agent
|
CA3023143A1
(en)
|
2016-06-15 |
2017-12-21 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
US10619169B2
(en)
|
2016-09-20 |
2020-04-14 |
Boehringer Ingelheim Vetmedica Gmbh |
EHV insertion site ORF70
|
BR112019005418A2
(pt)
|
2016-09-20 |
2019-10-01 |
Boehringer Ingelheim Vetmedica Gmbh |
novos promotores
|
KR102566066B1
(ko)
|
2016-09-20 |
2023-08-16 |
베링거잉겔하임베트메디카게엠베하 |
신규한 돼지 인플루엔자 백신
|
UY37405A
(es)
|
2016-09-20 |
2018-03-23 |
Boehringer Ingelheim Vetmedica Gmbh |
Vectores de adenovirus canino
|
CA3042584A1
(en)
|
2016-11-03 |
2018-05-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
|
EP3534945A1
(en)
|
2016-11-03 |
2019-09-11 |
Boehringer Ingelheim Vetmedica GmbH |
Vaccine against porcine parvovirus
|
CN110418650A
(zh)
|
2016-11-16 |
2019-11-05 |
免疫治疗有限公司 |
用于治疗过敏的核酸
|
WO2018140391A1
(en)
|
2017-01-24 |
2018-08-02 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
EA201991762A1
(ru)
|
2017-01-30 |
2020-01-23 |
Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. |
Вакцины против коронавируса свиней
|
WO2018187706A2
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
US11203629B2
(en)
|
2017-04-22 |
2021-12-21 |
Immunomic Therapeutics, Inc. |
LAMP constructs
|
WO2018204534A1
(en)
|
2017-05-02 |
2018-11-08 |
Immunomic Therapeutics, Inc. |
Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
|
KR20200027551A
(ko)
|
2017-07-11 |
2020-03-12 |
화이자 인코포레이티드 |
Cea muc1 및 tert를 포함하는 면역원성 조성물
|
US11179457B2
(en)
|
2017-07-12 |
2021-11-23 |
Boehringer Ingelheim Animal Health USA Inc. |
Senecavirus a immunogenic compositions and methods thereof
|
EP3661555A4
(en)
|
2017-08-01 |
2021-07-14 |
Ab Studio Inc. |
SPECIFIC ANTIBODIES AND USES THEREOF
|
US11311612B2
(en)
|
2017-09-19 |
2022-04-26 |
Geovax, Inc. |
Compositions and methods for generating an immune response to treat or prevent malaria
|
MY201967A
(en)
|
2017-09-23 |
2024-03-27 |
Boehringer Ingelheim Pharma |
Paramyxoviridae expression system
|
WO2019070161A2
(en)
|
2017-10-04 |
2019-04-11 |
Opko Pharmaceuticals, Llc |
ARTICLES AND METHODS FOR PERSONALIZED THERAPY OF CANCER
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
BR112020010137A2
(pt)
|
2017-11-24 |
2020-10-13 |
Eucure (Beijing) Biopharma Co., Ltd |
anticorpos anti-ox40 e usos dos mesmos
|
EP3755342A4
(en)
|
2018-02-21 |
2021-11-24 |
The University Of Montana |
DIARYL TREHALOSE COMPOUNDS AND THEIR USES
|
AU2019223768A1
(en)
|
2018-02-23 |
2020-08-27 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
|
EP3755716A4
(en)
|
2018-02-23 |
2021-08-04 |
Eucure (Beijing) Biopharma Co., Ltd |
ANTI-PD-1 ANTIBODIES AND THEIR USES
|
WO2019169313A1
(en)
|
2018-03-02 |
2019-09-06 |
The University Of Montana |
Immunogenic trehalose compounds and uses thereof
|
CA3091960A1
(en)
|
2018-03-19 |
2019-09-26 |
Boehringer Ingelheim Vetmedica Gmbh |
New ehv insertion site ul43
|
EP3768307A1
(en)
|
2018-03-19 |
2021-01-27 |
Boehringer Ingelheim Vetmedica GmbH |
New ehv with inactivated ul18 and/or ul8
|
JP7162072B2
(ja)
|
2018-03-26 |
2022-10-27 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
免疫原性組成物を製造する方法
|
WO2019222281A1
(en)
|
2018-05-15 |
2019-11-21 |
Immunomic Therapeutics, Inc |
Improved lamp constructs comprising allergens
|
AU2018432434A1
(en)
|
2018-07-20 |
2021-01-28 |
Eucure (Beijing) Biopharma Co., Ltd |
Anti-CD40 antibodies and uses thereof
|
CA3110006A1
(en)
|
2018-09-12 |
2020-03-19 |
Eucure (Beijing) Biopharma Co., Ltd |
Anti-tnfrsf9 antibodies and uses thereof
|
CN112867506A
(zh)
|
2018-09-20 |
2021-05-28 |
勃林格殷格翰动物保健有限公司 |
抗猪流行性腹泻的鼻内载体疫苗
|
TW202027785A
(zh)
|
2018-09-20 |
2020-08-01 |
德商百靈佳殷格翰維美迪加股份有限公司 |
經修飾之pedv棘蛋白
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
CN113227142B
(zh)
|
2018-11-19 |
2022-11-29 |
百奥赛图(北京)医药科技股份有限公司 |
抗pd-1抗体及其用途
|
US20220062394A1
(en)
|
2018-12-17 |
2022-03-03 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
TW202043256A
(zh)
|
2019-01-10 |
2020-12-01 |
美商健生生物科技公司 |
前列腺新抗原及其用途
|
KR20220018503A
(ko)
|
2019-05-23 |
2022-02-15 |
더 유니버시티 오브 몬타나 |
Tlr 수용체 리간드에 기반한 백신 애주번트
|
CN111979203B
(zh)
*
|
2019-05-24 |
2022-08-19 |
杭州功楚生物科技有限公司 |
携带cttnbp2nl基因的溶瘤痘苗病毒、构建方法及在制备抗肿瘤药物中的用途
|
EP4045528A1
(en)
|
2019-10-18 |
2022-08-24 |
Immunomic Therapeutics, Inc. |
Improved lamp constructs comprising cancer antigens
|
CR20220220A
(es)
|
2019-11-18 |
2022-09-20 |
Janssen Biotech Inc |
Vacunas basadas en calr y jak2 mutantes y sus usos
|
EP4100420A1
(en)
|
2020-02-06 |
2022-12-14 |
Boehringer Ingelheim Vetmedica GmbH |
Polypeptides useful for detecting anti-rhabdovirus antibodies
|
TW202144389A
(zh)
|
2020-02-14 |
2021-12-01 |
美商健生生物科技公司 |
在多發性骨髓瘤中表現之新抗原及其用途
|
TW202144388A
(zh)
|
2020-02-14 |
2021-12-01 |
美商健生生物科技公司 |
在卵巢癌中表現之新抗原及其用途
|
WO2021209897A1
(en)
|
2020-04-13 |
2021-10-21 |
Janssen Biotech, Inc. |
Psma and steap1 vaccines and their uses
|
US20230024133A1
(en)
|
2020-07-06 |
2023-01-26 |
Janssen Biotech, Inc. |
Prostate Neoantigens And Their Uses
|
WO2022009052A2
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
WO2022009051A1
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
A method for determining responsiveness to prostate cancer treatment
|
JP2023544403A
(ja)
|
2020-10-05 |
2023-10-23 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
サーコウイルス科カプシドタンパク質を含む融合タンパク質、及びそれから構成されるキメラウイルス様粒子
|
EP4225776A1
(en)
|
2020-10-05 |
2023-08-16 |
Boehringer Ingelheim Vetmedica GmbH |
Fusion protein useful for vaccination against rotavirus
|
WO2023194913A1
(en)
|
2022-04-05 |
2023-10-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic composition useful for vaccination against rotavirus
|
WO2023201201A1
(en)
|
2022-04-10 |
2023-10-19 |
Immunomic Therapeutics, Inc. |
Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof
|
WO2024011250A1
(en)
|
2022-07-08 |
2024-01-11 |
Viromissile, Inc. |
Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof
|
WO2024015892A1
(en)
|
2022-07-13 |
2024-01-18 |
The Broad Institute, Inc. |
Hla-ii immunopeptidome methods and systems for antigen discovery
|